Location: United Kingdom
The pen can accurately distinguish between Parkinson’s symptoms and other types of conditions which affect the nervous system and movement.
According to Parkinson’s UK, about 145 000 people in the UK are diagnosed with the condition. However, the condition can be challenging to diagnose with no single test present to confirm the disease. Diagnosis requires a referral to a specialist who uses their judgement based on symptoms and medical history. Lack of referral accuracy can be costly for healthcare systems. This traditional method of diagnosis usually depends on signs being fairly noticeable, eliminating the chance for early specialist care.
The NeuroMotor Pen can distinguish between Parkinson’s symptoms and other similar conditions, such as essential tremors. The program consists of a secure tablet and the pen where patients go through nine tests, following shapes and patterns. The artificial intelligence can distinguish between tremors caused by Parkinson’s or other conditions that might be difficult to identify by eye. The pen is sensitive enough to detect tremors before they are noticeable to the patient or doctor, providing an opportunity for early intervention
An accurate diagnosis of the patient’s symptoms means GPs or primary care doctors can refer patients to the appropriate specialists, or deal with another condition in their clinic. This might save costs for the healthcare system by preventing an unnecessary appointment but also save time or travel for the patient and allow a valuable slot to be offered to someone else. The device can also be used to assess response to treatment by comparing to the initial results. Path Finder is another MedTech device for those who have Parkinson’s; it seeks to improve walking issues.